Bulbar function in children with spinal muscular atrophy type 1 treated with nusinersen
Developmental Medicine & Child Neurology · 2025-12 · 67 (12) · 1590-1600
DOI: 10.1111/dmcn.16387 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 12.06.2025. Verfasst von Georgia Stimpson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, UK. Hauptthemen laut MEDLINE: Oligonucleotides, Outcome Assessment, Health Care, Spinal Muscular Atrophies of Childhood. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Muscular Dystrophy UK, MRC Translational Research Centre, Famiglie SMA, Telethon.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To describe bulbar function trajectories in patients with spinal muscular atrophy (SMA) type 1 treated with nusinersen in the UK and Italy.
Method
In two previously reported, retrospective, observational cohort studies, we observed the 2‐year change in the Children's Eating and Drinking Ability Scale (CEDAS) (the revised and optimized version of the Paediatric Functional Oral Intake Scale [p‐FOIS]) and Oral and Swallowing Ability Tool (OrSAT) in 44 patients treated on average at 8.3 months (interquartile range = 4.1–14.4 months), with data collected every 6 months from treatment initiation. [Correction added on 30 June 2025 after first online publication: In the preceding sentence, 11.2 months (interquartile range = 4.1–24.7 months) has been changed to 8.3 months (interquartile range = 4.1–14.4 months).]
Results
The Italian cohort had more participants in the 1b group (symptom onset >2 weeks and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, UK.
- Pediatric Neurology Unit, Catholic University, Rome, Italy.
- Centro Clinico NeMO, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
- National Institute for Health and Care Research, Great Ormond Street Hospital Biomedical Research Centre, London, UK.
- Speech and Language Therapy Department, Great Ormond Street Hospital, London, UK.
- Neuromuscular Department, Great Ormond Street Hospital, London, UK.
ORCID-Profile: Georgia Stimpson, Giovanni Baranello
Förderung
- Muscular Dystrophy UK
- MRC Translational Research Centre
- Famiglie SMA, Telethon
- Biogen
- NIHR Great Ormond Street Hospital Biomedical Research Centre
Zitieren
APA
Stimpson, G., Fanelli, L., Conway, E., Johnson, E., Berti, B., Scoto, M., Muntoni, F., Mercuri, E., Baranello, G., & p‐FOIS/CEDAS and OrSAT Working Group (2025). Bulbar function in children with spinal muscular atrophy type 1 treated with nusinersen. Developmental Medicine & Child Neurology, 67(12), 1590-1600. https://doi.org/10.1111/dmcn.16387
Vancouver
Stimpson G, Fanelli L, Conway E, Johnson E, Berti B, Scoto M, et al. Bulbar function in children with spinal muscular atrophy type 1 treated with nusinersen. Developmental Medicine & Child Neurology. 2025;67(12):1590-1600. doi:10.1111/dmcn.16387
BibTeX
@article{Stimpson2025,
author = {Stimpson, Georgia and Fanelli, Lavinia and Conway, Eleanor and Johnson, Emily and Berti, Beatrice and Scoto, Mariacristina and Muntoni, Francesco and Mercuri, Eugenio and Baranello, Giovanni and p‐FOIS/CEDAS and OrSAT Working Group, p‐FOIS/CEDAS and OrSAT Working Group},
title = {Bulbar function in children with spinal muscular atrophy type 1 treated with nusinersen},
journal = {Developmental Medicine & Child Neurology},
year = {2025},
volume = {67},
number = {12},
pages = {1590--1600},
doi = {10.1111/dmcn.16387}
}
EUVIMED